Author/Authors :
Robertson، نويسنده , , Fredika M and Parrett، نويسنده , , Michelle L and Joarder، نويسنده , , Farahnaz S and Ross، نويسنده , , Mary and Abou-Issa، نويسنده , , Hussein M and Alshafie، نويسنده , , Galal and Harris، نويسنده , , Randall E، نويسنده ,
Abstract :
A single dose of 75 mg/kg 7,12 dimethylbenz[a]anthracene was administered to 50-day-old virgin female Sprague–Dawley rats and 100 days later, animals were randomized and provided with Teklad rodent chow mixed with a dose of 25 mg/rat/day ibuprofen for 35 days. Ibuprofen treatment reduced tumor volume (P<0.05) and significantly inhibited gene expression of both cyclooxygenase-1 and cyclooxygenase-2 (P<0.02). These results indicate that ibuprofen induced significant regression of established mammary carcinomas which was associated with inhibition of expression of isoforms of the gene responsible for prostaglandin production.
Keywords :
Mammary carcinoma , NSAIDS , IBUPROFEN , COX , Prostaglandin G/H synthase